Click this link for the Dialogs in Knowledge and Technology Transfer 2008

Dialogs in Knowledge and Technology Transfer 2009

Optimizing KTT pathways for unmet therapeutic needs

The workshop aims was to examine the challenges facing Knowledge and Technology Transfer pathways in therapeutic treatments with a focus on neglected diseases and providing treatments to poor and developing countries.

Public research organizations (PROs) have to maximize the likelihood of having their results being used to the benefit of mankind. Compared to the well established KTT pathways to develop and market therapeutic treatments for widespread pathologies in developed countries, there is a lack of clear optimal KTT routes to do so in to poor and developing countries.

· Should PROs work primarily with pharmaceutical companies and embed in their KTT agreements safeguards to maximize diffusion ?

· Does patent pooling provides the incentives necessary to assure continuous development of life sciences innovations ?

· When are foundations or other non for profit organizations focused on specific diseases more efficient in making therapeutic products widely available ?

· What are the missing blocks in term of IP policy or KTT pathways that prevent an efficient transfer and development of early stage life sciences results from research to the marketplace ?

· More generally how to develop and market “non commercial” innovations ?

To address these important issues, a selection of participants/speakers based on the relevance of their activities and experience outlined and discussed new Knowledge and Technology Transfer (KTT) models that are developed to address these challenges faced by PROs when supporting the diffusion of their research results.

The venue was provided by Boston University, School of Management (www.bu.edu/smg) with the support of Kauffman Foundation and ITEC.

Date: Tuesday October 27^th, 2009.

Program committee: Iain Cockburn (cockburn@bu.edu), Michael Meurer (meurer@bu.edu), Laurent Mieville (mieville@bu.edu) , Kevin Outterson (mko@bu.edu) , Jonathan Rosen (jjr10@bu.edu ), Ashley Stevens (astevens@bu.edu).

Program of the workshop

8:30 - 9:00 Workshop registration, Welcome Coffee

9:00 – 9:10 Opening by Laurent Miéville, Welcome by Maureen O’ O’Rourke, Dean Boston University Law School

9.10 - 10.40 Session 1: Business models for orphaned drugs

10:40 - 11:00 Coffee break

11:00 - 12.30 Session 2: Patent pooling or other new licensing models in life sciences to streamline market diffusion of new products

12.30 - 1.30 Lunch

1.30 - 3.00 Session 3: The Role of Not-for-Profits and other Intermediaries in Fostering of Open Innovation and Diffusion

3.00 - 3.30 Coffee break

3.30 - 5.00 Session 4: Role of non-for profits or other intermediary as open innovation agents between research and market

5.00 - 5:30 Wrap-up & concluding remarks, next steps by Jonathan Rosen

5:30 – 7:00 Networking reception

List of Participants

Academics Participants

Last Name	First Name	Organization
Allan	Mark	Director, Health Management Program, Business Policy and Law, BU, Profile
Agrawal	Ajay	Professor, University of Toronto School of Mangement, Toronto, Canada, Profile
Bessen	Jim	Lecturer in Law at Boston University Law School, MA, Profile
Carlile	Paul	Associate Professors, Boston University, Boston, MA, Profile
Gajardo Cabedo	Fernando	MBA student, Boston University, Boston, MA, Profile
Cockburn	Iain	Professor, Boston University, School of Management, Profile
Conti	Annamaria	Research Affiliate, GeorgiaTech School of Management
Fischer	William	Professor, Director at The Berkman Center for Internet & Society at Harvard University , MA Profile
Gaule	Patrick	Research Associate, MIT, Profile, USA
Kaplan	Warren	Assistant Professor of International Health at Boston University, Profile
Keusch	Gerald	Special Assistant to the President for Global Health, Boston University, MA, Profile
Krestin	Ruth	Grad Student in Technology and Policy at MIT , MA Profile
Meurer	Michael	Professor and Michaels Faculty Scholar, Boston University Law School, MA, Profile
Miller	Fran	Professor, Boston University Law School, MA, Profile
Moncrieff	Abigail	Associate Professor, Boston University School of Law, MA, Profile
Murray	Fiona	Associate Professor, MIT Sloan School of Mangement, Profile
O’Mahony	Siobhan	Associate Professor Boston University School of Management, MA, Profile
Outterson	Kevin	Professor Boston University Law School, Profile
Pollastri	Michael	Associate Professor, Northeastern University, Boston,MA, Profile
Rosen	Jonathan	Director, Inst. for Technology Entrepreneurship and Commercialization (ITEC), Boston University, Profile
Rossini	Carolina	Fellow at The Berkman Center for Internet & Society at Harvard University, Profile
Ruckenstein	Andrei	Associate Provost and Vice President for Research at Boston University, Profile
Santore	Catherine	Assistant Director, Inst. for Technology Entrepreneurship and Commercialization, Boston University, Profile
Simcoe	Timothy	Assistant Professor, Strategy and Innovation, Boston University, Profile
Stern	Scott	Professor of Management & Strategy, Northwestern University, Profile
Waning	Brenda	Director of Pharmaceutical Policy, BU School of Medicine, MA,
TTO/ Non for Profits	Participants
Last Name	First Name	Organization
Abboud	Labeeb	Senior Vice President & General Counsel, International AIDS Vaccine Initiative, New York, Profile
Ashlock	Melissa	VP Drug Discovery, Cystic Fibrosis Foundation, Bethesda,MD, Profile
Bromley	Russell	COO, Myelin Repair Foundation, Saratoga, CA, Profile
Driscoll	Claire	Director, Technology Transfer Office National Human Genome Research Institute (NHGRI), NIH, Profile
Gournier	Hélène	Director Technology Transfer, Institut Curie, , Paris, France, Profile
Hughes	Owen	Senior Counsel, Initiative for Open Innovation, Cambia Technology, Australia, Profile
Jia	Xi Xi	Marketing Associate, MIT Technology Licensing Office, Cambridge, MA, Profile
Miéville	Laurent	Director of Technology Transfer, Uni Geneva, Visiting scholar BU, Profile
Mihailov	George	Director, Office of Technology Transfer, Sofia University, Bulgaria, Profile
Love	James	Director of Knowledge Ecology International, Washington, Profile
Ober	Stephen	Director New Ventures, Boston University Office of Technology Development, MA, Profile
Stevens	Ashley	Director of Technology Transfer and senior researcher, BU, Profile
Toneguzzo	Frances	Director, Massachusetts General Hospital Corporate Sponsored Research & Licensing, Profile
Wosinska	Marta	Director for Analysis Staff at FDA, Washington, Profile
Business Participants
Last Name	First Name	Organization
Chase	Philip	Vice-President Legal, Alnylam Pharmaceuticals, Inc., Cambridge, MA, Profile
Keenan	Rick	Vice-President at GSK, Philadelphia, Profile
Munos	Bernard	Advisor, Corporate Strategy, Eli Lilly, Indianapolis, Profile
Newland	Bart	VP, Intellectual Property, Genzyme Inc. , Cambridge, MA, Profile
Nguyen	Thinh	Counsel, Science Commons, Creative Commons, San Francisco, CA, Profile
O’Connell	Damian	Vice President, Clinical Research Head for the Indications Discovery Unit, Pfizer, United Kingdom, Profile (Drug Discovery Partnership)
Pan	Lydia	Director of Science Policy, Pfizer, New London, CT, Profile
Sorensen	Craig	Senior Director of R&D Network Design and Technology Integration, Vertex, Cambridge, MA, Profile
Wilson	Charles	Global Head of Strategic Alliances, Novartis Institutes for Biomedical Research Profile
Wilbanks	John	VP Science, Creative Commons, San Francisco, CA, Profile
VCs Participants
Last Name	First Name	Organization
Sandoski	Aaron	Managing Director, Norwichventures, Waltham, MA, Profile,
Eggimann	Anne-Virginie	General Manager and Project Director, Drugs and Biologics, Cambridge, MA, Profile
Mahadevia	Ankit	Associate at Atlas Venture, Waltham, MA, Profile